We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You may need to tell DVLA if you have lung cancer - download the correct form if you need to let them know
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Use the risk potential assessment form to initiate a project validation review, a project assessment review or an OGC Gateway review.
Comparing the uptake of NHS bowel, breast and cervical cancer screening services between people with and without severe mental illness.
This prostate cancer risk management programme (PCRMP) information is to help GPs advise men aged 50 and over who ask about prostate specific antigen (PSA) testing.
A statement from the Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC).
Information for patients, public and health care professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).